CIK 0001781174
- Emerging growth company
Acrivon Therapeutics, Inc.
Sign in to watch- Ticker
- ACRV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 825125532
- Phone
- +1 617-207-8979
- Business address
- 480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,498
- in 3 filings
Net −$32,498. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-26 | Miller Mary Chief Legal Officer | Grant or award | +3,858 | 44,287 | ||
| 2023-09-26 | Miller Mary Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +11,576 | 11,576 | ||
| 2023-08-21 | Blume-Jensen Peter President and CEO | Grant or award | +493,994 | 2,897,696 | ||
| 2023-06-26 | Chione Ltd 10% owner | Sale | −16 | $12.93 | $207 | 3,848,632 |
| 2023-06-22 | BAUM CHARLES M Director | Grant or award · Stock Option (Right to Buy) | +32,500 | 32,500 | ||
| 2023-06-16 | Holm-Jorgensen Rasmus Chief Financial Officer | Option exercise | +9,500 | $3.63 | $34K | 29,530 |
| 2023-06-16 | Holm-Jorgensen Rasmus Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −9,500 | 183,119 | ||
| 2023-06-15 | Chione Ltd 10% owner | Sale | −2,056 | $12.14 | $25K | 3,848,648 |
| 2023-06-14 | Chione Ltd 10% owner | Sale | −893 | $12.13 | $11K | 3,850,704 |
| 2023-06-13 | Chione Ltd 10% owner | Sale | −3,000 | $12.30 | $37K | 3,851,597 |
| 2023-06-12 | Chione Ltd 10% owner | Sale | −2,000 | $12.34 | $25K | 3,854,597 |
| 2023-06-05 | Devroe Eric Chief Operating Officer | Option exercise | +9,225 | $1.04 | $10K | 62,883 |
| 2023-06-05 | Devroe Eric Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −9,225 | 96,615 | ||
| 2023-05-31 | Blume-Jensen Peter President and CEO | Option exercise | +33,605 | $3.88 | $130K | 2,403,702 |
| 2023-05-31 | Blume-Jensen Peter President and CEO | Option exercise · Stock Option (Right to Buy) | −33,605 | 90,855 | ||
| 2022-11-17 | Chione Ltd 10% owner | Purchase | +400,000 | $12.50 | $5.0M | 3,856,597 |
| 2022-11-17 | Chione Ltd 10% owner | Conversion | +3,445,940 | 3,856,597 | ||
| 2022-11-17 | Chione Ltd 10% owner | Conversion | +10,657 | 3,856,597 | ||
| 2022-11-17 | Chione Ltd 10% owner | Conversion · Series A-1 Preferred Stock | −8,497,692 | 0 | ||
| 2022-11-17 | Chione Ltd 10% owner | Conversion · Series B Preferred Stock | −26,281 | 0 |
Page 10 of 12 · 229 trades